Company Filing History:
Years Active: 2016
Title: Nitin Sharadchandra Pradhan: Innovator in Pharmaceutical Chemistry
Introduction
Nitin Sharadchandra Pradhan is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of two patents to his name, Pradhan's work focuses on innovative solutions for treating thromboembolic disorders.
Latest Patents
Pradhan's latest patents include the invention of a novel intermediate for rivaroxaban and its preparation process. This invention relates to a unique intermediate, formula (A), which is used in the synthesis of rivaroxaban. The process involves treating this intermediate with 5-chlorothiophene carbonyl chloride to produce rivaroxaban derivatives, formula (B). The subsequent treatment of formula (B) with acid results in the formation of rivaroxaban.
Another significant patent by Pradhan is the aldehyde derivative of substitute oxazolidinones. This invention pertains to a prodrug of a specific compound, which is chemically designated as 5-chloro-N-formyl-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide. The processes for preparing this prodrug and its application in the treatment and prophylaxis of thromboembolic disorders highlight the importance of his research.
Career Highlights
Nitin Pradhan is currently associated with Wanbury Limited, where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of drug development.
Collaborations
Pradhan collaborates with talented professionals in his field, including Nilesh Sudhir Patil and Rajesh Ramchandra Walavalkar. These collaborations enhance the research and development efforts at Wanbury Limited.
Conclusion
Nitin Sharadchandra Pradhan is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents reflect his commitment to advancing medical treatments, particularly for thromboembolic disorders.